1.5 Abstract in rivista
 Distribuzione geografica
Continente #
NA - Nord America 71.274
AS - Asia 39.710
SA - Sud America 28.818
EU - Europa 27.100
AF - Africa 1.584
OC - Oceania 182
Continente sconosciuto - Info sul continente non disponibili 159
AN - Antartide 2
Totale 168.829
Nazione #
US - Stati Uniti d'America 69.844
BR - Brasile 25.820
SG - Singapore 15.999
CN - Cina 13.675
UA - Ucraina 10.148
SE - Svezia 4.264
DE - Germania 4.163
HK - Hong Kong 3.530
IT - Italia 2.305
FI - Finlandia 1.762
VN - Vietnam 1.474
GB - Regno Unito 1.120
AR - Argentina 1.060
FR - Francia 922
TR - Turchia 752
RU - Federazione Russa 591
EC - Ecuador 525
MX - Messico 521
BD - Bangladesh 510
IQ - Iraq 507
CA - Canada 470
ZA - Sudafrica 458
IN - India 449
UZ - Uzbekistan 423
MA - Marocco 359
VE - Venezuela 357
PK - Pakistan 322
CO - Colombia 289
BE - Belgio 240
KR - Corea 222
JP - Giappone 199
PL - Polonia 187
PY - Paraguay 186
UY - Uruguay 185
KE - Kenya 180
ES - Italia 171
CZ - Repubblica Ceca 170
TN - Tunisia 169
PE - Perù 167
AZ - Azerbaigian 154
AU - Australia 153
ID - Indonesia 152
JO - Giordania 147
NL - Olanda 145
CL - Cile 140
AE - Emirati Arabi Uniti 130
DZ - Algeria 126
EU - Europa 119
AT - Austria 114
NP - Nepal 110
KZ - Kazakistan 95
DO - Repubblica Dominicana 94
OM - Oman 87
EG - Egitto 85
IR - Iran 81
RS - Serbia 80
AL - Albania 78
BO - Bolivia 76
SA - Arabia Saudita 76
IL - Israele 75
LT - Lituania 74
RO - Romania 73
KG - Kirghizistan 68
IE - Irlanda 67
JM - Giamaica 66
PA - Panama 63
PS - Palestinian Territory 61
LB - Libano 60
GE - Georgia 57
HN - Honduras 56
BY - Bielorussia 50
SN - Senegal 49
BG - Bulgaria 46
CR - Costa Rica 45
BH - Bahrain 39
AM - Armenia 33
NI - Nicaragua 33
PH - Filippine 33
CH - Svizzera 32
GR - Grecia 32
XK - ???statistics.table.value.countryCode.XK??? 30
GT - Guatemala 29
MD - Moldavia 29
NZ - Nuova Zelanda 29
BA - Bosnia-Erzegovina 28
AO - Angola 27
SK - Slovacchia (Repubblica Slovacca) 27
BN - Brunei Darussalam 26
GA - Gabon 25
KW - Kuwait 25
CI - Costa d'Avorio 24
HU - Ungheria 23
DK - Danimarca 22
NG - Nigeria 22
NO - Norvegia 22
PT - Portogallo 22
SY - Repubblica araba siriana 22
HR - Croazia 21
SV - El Salvador 21
MN - Mongolia 18
Totale 168.541
Città #
Dallas 28.022
Chandler 8.735
Singapore 7.674
Jacksonville 6.412
Hong Kong 3.489
Dearborn 3.399
Princeton 3.348
Nanjing 2.922
Beijing 2.544
São Paulo 1.806
Ashburn 1.704
Wilmington 1.376
Nanchang 1.115
Shanghai 1.089
Boardman 1.034
Ann Arbor 817
New York 797
Rio de Janeiro 779
Belo Horizonte 706
Los Angeles 677
Shenyang 673
Tianjin 609
Hebei 597
Ho Chi Minh City 580
Brasília 502
Changsha 489
Jiaxing 485
Santa Clara 439
Sassari 412
Tashkent 379
Curitiba 376
Woodbridge 359
Porto Alegre 357
Buffalo 306
Campinas 302
Hanoi 299
Munich 295
Kunming 294
Guarulhos 276
Jinan 253
Salvador 245
Hangzhou 241
San Francisco 240
Norwalk 239
Baghdad 238
Brussels 234
Seoul 215
Helsinki 203
Johannesburg 194
Toronto 193
Goiânia 192
Tokyo 181
Ribeirão Preto 180
Fortaleza 179
Guayaquil 178
Warsaw 164
Santo André 162
Quito 157
Nairobi 156
Manaus 152
Sorocaba 150
Zhengzhou 149
Istanbul 147
Montevideo 147
Recife 146
Baku 145
Caxias do Sul 145
São José dos Campos 144
Guangzhou 142
Amman 141
Dhaka 141
Ningbo 138
Campo Grande 136
Montreal 133
Uberlândia 133
Rome 132
Betim 129
Brooklyn 129
Contagem 129
São José do Rio Preto 128
Brno 127
Joinville 127
Osasco 126
São Bernardo do Campo 122
Stockholm 121
London 120
Izmir 119
Lima 118
Mountain View 118
Turku 117
Pelotas 114
Grafing 112
Denver 111
Juiz de Fora 110
Chicago 108
Atlanta 106
Buenos Aires 104
Casablanca 104
Frankfurt am Main 100
Nuremberg 100
Totale 95.738
Nome #
HETEROGENEITY OF TYPE 1 GASTRIC NEUROENDOCRINE NEOPLASMS 339
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED, STAGE IV DIGESTIVE ENDOCRINE TUMORS 337
Reassessment of Proliferative Activity at Disease Progression in Neuroendocrine Neoplasms 333
Curative Resection in Digestive Neuroendocrine Neoplasms: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence 324
Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 318
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 317
Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms 317
Contrast Enhanced Ultrasonography (CEUS) and Quantitative Perfusion Analysis in the Assessment of Neuroendocrine Liver Metastases 315
FOLFOX Chemotherapy: Efficacy and Tolerability in Advanced Digestive Neuroendocrine Neoplasms (NENs) 315
Peritoneal Carcinomatosis in Digestive Neuroendocrine Neoplasms: Complications and Response to Therapy 313
Accuracy of the Novel TNM Staging System in the Prognostic Stratification of Patients With Advanced, Stage IV Digestive Endocrine Tumors 312
Evaluation of Multidisciplinary Tumor Board Decisions in the Management of Neuroendocrine Tumors: Impact of Expert Centers 306
Role of Somatostatin Receptors scintigraphy in neuroendocrine neoplasms follow-up 305
REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS 302
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 301
Risk and protective factors for midgut carcinoid tumors: Multicenter case-control study of prospectively evaluated patients 299
Risk and Protective Factors for Midgut Carcinoid Tumours: Multicenter Case-Control Study of Prospectively Evaluated Patients 296
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 291
Histopathological Revision forGastroenteropancreatic NeuroendocrineNeoplasms in Expert Centers: Does It Make theDifference? 290
Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up 284
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 263
A possible prognostic role for MSRV in multiple sclerosis. 252
Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma 251
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 251
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl 3-({[(5-hydroxy-4-oxo-4H-pyran-2- yl)methoxy]carbonyl}amino)propanoate. Synthesis and its complex formation study 248
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 246
Adherence to Acrysof intraocular lenses by organisms causing chronic postoperative endophthalmitis 246
A reappraisal of Multiple Sclerosis risk in Sardinians. 243
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 233
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 232
Abitudini di igiene orale in studenti universitari della città di Sassari. 229
A Case of Multiple Sclerosis and Hydrosyringomyelia: A Non-Coincidental Association? 227
Adhesion properties of ocular isolates of Staphylococcus epidermidis 225
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 224
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 221
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 221
A reappraisal of multiple sclerosis risk among Sardinians. 212
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 210
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 210
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 207
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 207
Acquired hepatocerebral degeneration responsive to penicillamine: A case report 206
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 206
123I FP-CIT SPECT in early Parkinson’s disease 205
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 204
A double-blind European Multicenter Study Evidences envelope protein from Human Endogenous Retrovirus W (MSRV-ENV or Syncytin) in serum from 73% of MS patients without selective clinical inclusion criteria 199
APPLICATION OF 2009/127/EC AND 2009/128/EC DIRECTIVES IN SARDINIA (ITALY): RESULTS ON SPRAYING MACHINES 197
A Proteomic Approach To Characterize A Native Antigen Involved In Autoantibody Response In Multiple Sclerosis By A Structure-Based Designed Glycopeptide 196
Akt down regulation by CYP2C9-induced ROS generation mediate dose-dependent cell damage elicited by natural antioxidants in human endothelial cells 196
Abstracts from the IVECCS & EVECC Annual Congresses and the ACVECC VetCOT Veterinary Trauma & Critical Care Conference 2016 195
Autoinflammatory diseases in Dermatology: a peculiar case of familial mediterranean fever 193
Application of proximal and remote sensing on precision viticulture in Sardinia (Italy) – Preliminary results 193
Activation of endogenous retroviruses of the HERV-W family by Epstein Barr virus in vitro and in vivo: a dual virus model as the missing link with multiple sclerosis 193
Asymmetric color perception in the shopping aisle: some implications for merchandising 190
Analysis of gene expression of ovine pre-implantation embryos derived from in vitro fertilization and parthenogenetic activation 189
Accessi alle fratture dell’osso frontale e del basicranio anteriore 187
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 187
Analysis of fanconi anemia genes in colorectal cancer 186
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 185
A new sutureless technique for end-to-end and end-to-side arterial and prosthetic anastomosis 184
First report of grapevine black rot in Sardinia. 184
111In-pentetreotide SPECT/CT for functional anatomical mapping in patients with pulmonary carcinoid. 183
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 182
Archaeometric analyses on pottery of eneolithic age from central Sardinia. 181
Anthropological investigation on the remains of “Sa Figu” tomb II (Ittiri- Sassari) early bronze age 180
COMPARATIVE STUDY ON THE USE OF A NON-DESTRUCTIVE OPTICAL SENSOR (MULTIPLEX3®) FOR THE MONITORING OF THE ANTHOCYANINS CONTENT IN RED BERRY FRUITS 177
Analisi dei risultati a medio termine delle artrodesi strumentate lombari mediante approccio estremo laterale 176
A portable device for estimating the somatic cell count in sheep milk 176
Plasma taurine levels in age-related macular degeneration 175
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 175
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 174
99mTc-tetrofosmin SPECT: a useful diagnostic tool in breast cancer (BC) detection 172
A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE 172
12. Prolactin (PRL) response to Thyrotropin Releasing Hormone (TRH) in patients with subacute thyroiditis in the early stage. 170
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 169
Analisi descrittiva degli incidenti da traffico rilevati presso la A.U.S.L. 1 di Sassari nel periodo 1992-1996. 169
A NEW SUTURELESS TECNIQUE FOR END-TO-END AND END-TO-SIDE ARTERIAL AND PROSTHETIC ANASTOMOSIS 169
Caratteristiche morfologiche del disco intervertebrale lombare umano normale e patologico. 168
Acute respiratory paralysis in arsenic neuropathy following intravenous intoxication 167
Brainstem function in multiple sclerosis (MS): clinical, magnetic resonance imaging (MRI) and neurophysiological follow-up 166
Aesthethic refinements in orthognathic surgery: osteotomy versus implants in malar and chin augmentation 166
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 166
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 165
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 164
Acute hyponatremia and neuroleptic malignant syndrome 164
Anti-oxidant and anti-migration activity of supercritical carbon dioxide extracts of Pistacia lentiscus L. on human endothelial cells 163
Cadmium induced effects on morphology of glomerul cells of the rat kidney 158
Basal Expression and Regulation by Pro-Inflammatory Cytokines of Human Endogenous Retroviruses of The W Family in Bood Cell Subpopulations and in Astrocytes. 158
An ultrastructural study on the variability of interfacial morphology between a self etching system and carious and sclerotic dentin 158
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 157
Chemotherapy with paclitaxel, carboplatin and bleomycin for locally advanced or recurrent cervical cancer 157
Axillary lymph node dissection in T1a and T1b breast cancer. 157
A novel candidate gene in human endometrial cancer at chromosome 10q26 156
18p deletion syndrome: foetal phenotype and cytogenetic characterization 156
Antibiotic resistant H-pylori are extremely common in Sardinia. 155
Functional genomics analysis of Fusarium culmorum by random insertional mutagenesis with a MIMP1/IMPALA double-component system. 155
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 154
Addotti della ftalocianina di cobalto. Sintesi e caratterizzazione spettroscopica 154
A new disease of Erica arborea in Italy caused by Neofusicoccum luteum 154
111In-pentetreotide SPECT/CT in neuroendocrine tumors (NETs) 154
Totale 21.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.323 0 0 0 0 0 934 1.706 30 2.158 2.264 747 484
2021/20226.733 958 63 29 64 25 57 263 570 573 304 720 3.107
2022/202317.146 1.817 782 257 2.886 1.939 2.940 23 2.074 3.047 142 793 446
2023/20244.968 920 396 252 181 974 399 62 164 3 109 550 958
2024/202549.954 478 391 2.799 775 1.642 1.340 3.096 11.715 18.038 6.657 1.751 1.272
2025/202649.177 2.530 19.792 11.419 9.919 4.962 555 0 0 0 0 0 0
Totale 169.806